Panteion University of Social and Political Sciences
Συγκριτική διερεύνηση του νευροψυχολογικού προφίλ ασθενών με υποτύπους καταθλιπτικής διαταραχής: προεκτάσεις για την πρόβλεψη ανταπόκρισης στη θεραπεία
Abstract
dc:descriptionMajor Depressive Disorder (MDD) currently affects public health with lifetime prevalence of 10-25% for females and 5-12% for males. It is associated with cognitive deficits including memory, attention and cognitive flexibility, as well as executive functioning. Despite signicant advances in therapeutics, almost half of patients with MDD fail to show a satisfactory response to treatment and the prediction of treatment outcome remains unsatisfactory. Additionally, evidence suggests that MDD chonicity is associated with cognitive deterioration. Following the shift towards a dimensional approach to psychopathology, significant effort has been invested in differentiating depression subtypes and identifying early predictors of pharmacoresistance and treatment outcome for distinct subtypes. Early identification would facilitate the timely choice of the optimal intervention strategy. In this framework, three research approaches have addressed early identification of treatment resistant depression subtypes. The first approach relied on clinical features (“clinical MDD subtypes”) and has not been fruitful. The second approach, based on neuroimaging and neurobiological subtype differentiators, still holds promise but has not yet produced useful algorithms predicting the optimal treatment for individual patients. Furthermore, it remains expensive and therefore inaccessible to the majority of psychiatric departments. The third approach is the combination of clinical and neuropsychological features as indices of pharmacoresistant MDD subtypes. In line with this view, the aim of the present thesis was to investigate the neuropsychological profile of MDD patients showing resistance to current pharmacological treatments of depression. Within this research framework, three clinical studies examined two MDD populations characterized by pharmacoresistance. Specifically, one pharmacoresistant MDD group was characterized by referral for Electroconvulsive Therapy (ECT), the other consisted of patients with Dysthymic disorder. These groups were compared psychometrically and neuropsychologically with two control groups, one of non-psychiatric volunteers, the other of pharmacoresponsive MDD patients.
Degree
thesis:*- Grantor dc:publisher
- Panteion University of Social and Political Sciences
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kalogerakou, Stamatina
- Καλογεράκου, Σταματίνα
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45567